Cisplatin nephrotoxicity affects magnesium and calcium metabolism.

@article{Goren2003CisplatinNA,
  title={Cisplatin nephrotoxicity affects magnesium and calcium metabolism.},
  author={Marshall P. Goren},
  journal={Medical and pediatric oncology},
  year={2003},
  volume={41 3},
  pages={
          186-9
        }
}
Cisplatin is not directly toxic to bone, but cisplatin nephrotoxicity leading to magnesium wasting may affect magnesium and calcium metabolism, both of which contribute to bone integrity. The specificity of the magnesium lesion suggests that cisplatin may have an affinity for proteins that regulate magnesium absorption. Sulfhydryls such as amifostine can reduce the toxicity of cisplatin in adults, but current pediatric data do not indicate a role for sulfhydryl therapy to reduce cisplatin… CONTINUE READING
BETA

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 19 CITATIONS

[Effects of oncological therapy on bone disorders].

  • Pediatric endocrinology, diabetes, and metabolism
  • 2017
VIEW 1 EXCERPT
CITES BACKGROUND

Similar Papers